Cancer stem cell antigen vaccines and methods
US8129184B2 · kind B2 · utility
19Cited by
29References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 26, 2007 |
| Grant date | Mar 6, 2012 |
| Priority date | — |
| Expiry date | Dec 29, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of stimulating an immune response (e.g., to treat cancer) include administering to a patient a composition including dendritic cells that present cancer stem cell antigens. Compositions including cancer stem cell antigens are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.